Monarch Partners Asset Management LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$434,000
+40.5%
57,931
+96.8%
0.10%
+30.7%
Q2 2020$309,000
+103.3%
29,435
+70.1%
0.08%
+41.5%
Q1 2020$152,00017,3000.05%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders